Brief: Bioinvent Announces Data From Phase 1 Study In Solid Tumors
08/01/2025 06:57
Jan 8 (Reuters) - BioInvent International AB BINV.ST :
* ANNOUNCES PROMISING DATA FOR BI-1910 AS SINGLE AGENT FROM
PHASE
1 STUDY IN SOLID TUMORS
* DATA SHOW STABLE DISEASE AS BEST CLINICAL RESPONSE WITH NO
NOTABLE ADVERSE EVENTS
Source text: ID:nMFN6cgBlK
Further company coverage: BINV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))